The public consultation on the European Medicines Agency’s draft policy on publication and access to clinical-trial data ends on 30 September 2013.


Stakeholders have one more month to send their comments on the draft policy to the Agency.


Comments should be made using the submission form and sent no later than 30 September 2013 to


The draft policy outlines the rules for the publication and access to data from clinical trials submitted as part of a marketing-authorisation application, once the decision-making process has ended.


Posted on the EMA website on 30 August 2013